Lower medical costs associated with increased use of remote diabetes management and reduced blood glucose
Date published: May 2019
PEER-REVIEWED STUDY
This retrospective study investigates the financial impact of a remote digital diabetes management program using medical claims and real-time blood glucose data. Read the full study in the Journal of Medical Economics.
Related Insights
Clinical Study
Health Plans,
Clinical Study,
Virtual Care Platform
Helping one health plan accurately identify and review their most high-cost, complex cases
Clinical Study
Health Plans,
Diabetes,
Clinical Study,
Employers
Identifying people at risk for uncontrolled diabetes using machine learning
Clinical Study
Health Plans,
Clinical Study,
Primary Care,
Employers
Robust diagnosis system for virtual primary care
Clinical Study
Health Plans,
Clinical Study,
Mental Health,
Employers
Digital mental health program’s impact on anxiety and depression
Clinical Study
Health Plans,
Clinical Study,
Hypertension,
Employers
Trends of blood pressure control in the U.S. during the COVID-19 pandemic
Clinical Study
Health Plans,
Clinical Study,
Diabetes,
Employers
Improving outcomes with personalized recommendations for diabetes program
Clinical Study
Health Plans,
Clinical Study,
Diabetes,
Mental Health,
Employers
Predicting mental health risk for people with diabetes using machine-learning
Clinical Study
Health Plans,
Clinical Study,
Obesity & Weight Care,
Employers
Weight loss reduces medical costs for insured patients with chronic conditions
Clinical Study
Health Plans,
Clinical Study,
Diabetes,
Employers
The impact of a diabetes remote monitoring program on medication adherence
Clinical Study
Health Plans,
Clinical Study,
Diabetes,
Employers
CGM-based diabetes remote monitoring for poorly controlled type 2 diabetes